Quick Takeaways
- TANG CAPITAL MANAGEMENT LLC filed SCHEDULE 13D/A for Aurinia Pharmaceuticals Inc. Common Shares, no par value (AUPH).
- Disclosed ownership: 9.2%.
- Date of event: 23 Mar 2026.
Quoteable Key Fact
"TANG CAPITAL MANAGEMENT LLC disclosed 9.2% ownership in Aurinia Pharmaceuticals Inc. Common Shares, no par value (AUPH) on 23 Mar 2026."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original Filing| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT, LLC | 9.2% | 12,229,500 | 0 | 12,229,500 | /s/ Kevin Tang | Manager | 0001232621 |
| KEVIN TANG | 9.2% | 12,229,500 | 0 | 12,229,500 | /s/ Kevin Tang | Self | 0001178579 |
| TANG CAPITAL PARTNERS, LP | 5.3% | 6,990,461 | 0 | 6,990,461 | /s/ Kevin Tang | Manager, Tang Capital Management, LLC, General Partner | 0001191935 |
| TANG CAPITAL PARTNERS INTERNATIONAL, LP | 3.9% | 5,239,039 | 0 | 5,239,039 | /s/ Kevin Tang | Manager, Tang Capital Management, LLC, General Partner | |
| TANG CAPITAL PARTNERS III, INC | 0% | 0 | 0 | 0 | /s/ Kevin Tang | Chief Executive Officer | |
| TANG CAPITAL PARTNERS IV, INC | 0% | 0 | 0 | 0 | /s/ Kevin Tang | Chief Executive Officer |